_edited.png)
About
Empirics Economic Research (EER)
/ ABOUT US /
High-Quality Analytics Driving Informed Decisions
Welcome to Empirics Economic Research (EER), a consulting firm that leverages subject matter expertise and extensive experience in health economics & outcomes research (HEOR) methods to provide high-quality analytics solutions, advisory services and training for clients.
We are committed to transforming complex data into robust, actionable evidence that drives strategic decision-making. Our core focus is partnering with clients to design, execute, and disseminate methodologically rigorous studies—from end-to-end Real World Evidence (RWE) solutions to advanced health economic modeling—ensuring the resulting evidence meets the stringent standards of regulatory bodies, payers, and HTA agencies worldwide.
/ OUR MISSION /
Illuminating the Path to Compelling Insights
EER's mission is to become a trusted, collaborative, and indispensable consultancy at the vanguard of value evidence analytics that improves patients’ health outcomes. We achieve this by providing methodologically rigorous solutions across the entire evidence generation spectrum, including RWE, health economic modeling, and evidence synthesis. We are dedicated to translating complex empirical research into strategic insights that empower clients in the life sciences and beyond to demonstrate the true clinical and economic value of their innovations.
Why Work With Us?
EER's mission is to become a trusted, collaborative, and indispensable consultancy at the vanguard of value evidence analytics that improves patients’ health outcomes. We achieve this by providing methodologically rigorous solutions across the entire evidence generation spectrum, including RWE, health economic modeling, and evidence synthesis, dedicated to translating complex empirical research into strategic insights that empower clients to demonstrate true clinical and economic value.
/ OUR VALUES /
Core Values
Ethics & Integrity
EER ensures that all engagements, advice, and solutions are anchored in unwaveringly ethical conduct, trustworthiness, honesty, accuracy, and reliability.
Excellence
EER is committed to high-quality standards in methods and analytics solutions, ensuring excellent deliverables in all engagements.
Passion
EER is driven by enthusiasm for all matters economic analysis and insights, consistently striving to exceed expectations and deliver exceptional analytics services.
Collaboration
EER values diverse intellectual viewpoints that help drive relentless improvements in evidence generation engagements and deliverables.
How Are We Different?
Empirics Economic Research (EER) stands apart due to our uncompromising commitment to methodological rigor combined with applied commercial insight. We don't just process data; we bring deep subject matter expertise to strategically guide the entire evidence lifecycle—from choosing the most appropriate advanced econometrics or statistical model to preparing HTA-ready dissemination materials. Our consulting approach ensures that every analytical solution is fit-for-purpose, defensible to global payers, and directly translates complex research into credible, quantifiable value for your organization.
Leadership
Eric M. Sarpong, Ph.D.
Founder and President
Dr. Eric Sarpong is a Co-founder of Empirics Economic Research (EER). Dr. Sarpong is a dynamic microeconomist with extensive experience in innovative Health Economics & Outcomes Research (HEOR) including Real-World Evidence (RWE), Decision Analytic Modeling for Health Technology Assessment (HTA), and Evidence Synthesis. He previously served as Director, Outcomes Research at Merck & Co. Inc., Senior Economist at the Agency for Healthcare Research and Quality (AHRQ) and Senior Research Scientist at Eli Lilly & Co.
Dr. Sarpong has experience teaching microeconomics and macroeconomics courses within the economics departments at Georgia State University and Indiana University. His research interests span Health Economics, Labor Economics, and Economics overall with a focus on the effects of differences in key right-hand side (RHS) variables on policy-relevant, clinically meaningful left-hand side (LHS) variables including health outcomes, health policy and labor market outcomes. Dr. Sarpong has extensive and in-depth expertise in the methods Decision Analytic Modeling, Evidence Synthesis and Applied Econometrics - the latter techniques ranging from Limited Dependent Variables Models (Logit, Probit, Multinomial Logit/Probit), Oaxaca-Blinder Decomposition Analysis, Duration or Survival Analysis (Nonparametric, Semi-parametric, Parametric), Quasi-Experimental Method such as Propensity Scores, Difference-in-Differences (D-i-D), Interrupted Time Series (ITS) to causal analyses using Instrumental Variables (IV) techniques.
Dr. Sarpong has published extensively in peer-reviewed journals and serves as a referee for a number of peer reviewed journals. Dr. Sarpong received his Ph.D. and M.A. in Economics from the Andrew Young School of Policy Studies (AYSPS) at Georgia State University and B.B.A. in Accounting from Kennesaw State University.